Breaks Categories: Stock Spotlights

MondayFeb 06, 2017 11:15 am

NetworkNewsBreaks – Rosetta Genomics (NASDAQ: ROSG) Receives Two U.S. Patent Allowances for RosettaGx Reveal™ microRNAs

Rosetta Genomics (NASDAQ: ROSG) shares are nudging higher after the company said the U.S. Patents and Trademark Office has granted two patent allowances for divisional patents of the parent application titled “microRNAs and uses thereof.” The company said the patents are important markers for its RosettaGX Reveal™ thyroid cancer assay, as this strengthens its intellectual property portfolio and provides opportunities for monetization. “We are creating a strong intellectual property position in microRNAs and thyroid cancer diagnostics. Of note, there are approximately 500 peer-reviewed publications that confirm the effectiveness of microRNAs as biomarkers in the diagnosis of thyroid cancer which makes…

Continue Reading

FridayFeb 03, 2017 3:44 pm

NetworkNewsBreaks – Soligenix, Inc.’s (NASDAQ: SNGX) SGX301 Receives Promising Innovative Medicine Designation in the UK; Aegis Capital Increases PT to $7

Shares of Soligenix (NASDAQ: SNGX) continued to climb Friday following the company’s announcement yesterday that its SGX301 was granted Promising Innovative Medicine (PIM) designation in the United Kingdom by the Medicines and Healthcare Products Regulatory Agency for the treatment of cutaneous T-cell lymphoma. The PIM designation is the first step toward inclusion in the Early Access to Medicines Scheme (EAMS), which provides severely ill patients with life-threatening and seriously debilitating conditions early access to groundbreaking new medicines - before marketing authorization is approved. "This is now the second of our programs to receive this important designation, with the first being…

Continue Reading

FridayFeb 03, 2017 12:15 pm

NetworkNewsBreaks – FDA Accepts Filing of Intellipharmaceutics’ (NASDAQ: IPCI) NDA for Rexista™; Aegis Reiterates ‘Buy’ Rating and $8 PT

Shares of Intellipharmaceutics International (NASDAQ: IPCI) are slightly higher following news late yesterday that the FDA has accepted the company’s filing of a New Drug Application (NDA) for Rexista™ for the management of moderate to severe pain. Pivotal pharmacokinetic and abuse-deterrent studies have shown Intellipharmaceutics’ Rexista as bioequivalent to OxyContin®. "The acceptance of filing of our NDA for Rexista™ represents an important step towards the commercialization of a potentially best–in-class abuse-deterrent oxycodone hydrochloride extended release product.  We look forward to working with the FDA during their review of our NDA submission," Intellipharmaceutics CEO Dr. Isa Odidi stated in the news…

Continue Reading

ThursdayFeb 02, 2017 12:27 pm

NetworkNewsBreaks – Check-Cap (NASDAQ: CHEK) Advances toward Regulatory Approval of Colonoscopy Alternative, C-Scan®

Check-Cap (NASDAQ: CHEK) is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the screening of precancerous polyps and cancer. The company’s C-Scan® system provides an alternative to the current Colorectal Cancer (CRC) screenings, such as a colonoscopy, to help increase screening rates. Unlike a colonoscopy, Check-Cap’s system doesn’t require a bowel prep, which is a huge selling point for at-risk patients. Check-Cap recently enrolled the first patient in its multi-center study of the C-Scan® system in support of its plans to submit for a CE Mark in the first…

Continue Reading

ThursdayFeb 02, 2017 12:21 pm

NetworkNewsBreaks – Propanc Health Group Corp. (PPCH) Continues to Advance Pipeline of Anti-Cancer Products

Propanc (OTCQB: PPCH) is a development-stage health care company working to advance its pipeline of new and proprietary treatments for cancer patients suffering from solid tumors toward clinical trials. The company recently issued an update on the progress of additional pending patent applications, noting that it had received a written opinion from the International Search Authority regarding a recent Patent Cooperation Treaty application filed in Australia. The majority of claims in the written opinion were considered novel and inventive, as determined by the authorized officer from the Australian Patent Office. The company’s patent application in Spain, titled "Cancer Treatment," was…

Continue Reading

ThursdayFeb 02, 2017 12:18 pm

NetworkNewsBreaks – Sunworks, Inc. (NASDAQ: SUNW) Shares Nudge Higher on Patent for 3D Solar Cell Technology

Sunworks (NASDAQ: SUNW) is trading higher following word that the solar company was granted a patent for its 3D solar cell technology. Issued by the Chinese Patent Office, the patent is titled 'Three-Dimensional Power Systems and Methods of Making Same'. According to the news release, the patented cell collects sunlight from wider angles and causes light to bounce within its 3-dimensional microstructure. The process continues until the cell is fully absorbed, thereby maximizing the rate of conversion from sunlight to electricity. Sunworks also recently entered into a partnership with Ecoark Holdings (OTCQX: EARK), a technology company that develops supply chain…

Continue Reading

ThursdayFeb 02, 2017 10:49 am

NetworkNewsBreaks – Vanguard Natural Resources (NASDAQ: VNR) Files for Chapter 11 Protection; Shares Tumble

Vanguard Natural Resources (NASDAQ: VNR) shares dropped more than 60% in early trade after the company announced it has voluntarily filed petitions for Chapter 11 bankruptcy.  In addition, the company has entered into a Restructuring Support Agreement with certain consenting holders of the company's 7.875% Senior Notes due 2020, 8 3/8% Senior Notes due 2019 and 7.0% Senior Secured Second Lien Notes due 2023. Vanguard said it intends to use this agreement to eliminate approximately $708 million in debt under its reserve-based credit facility and senior unsecured debt. "We continue to believe in the quality of our asset base and…

Continue Reading

ThursdayFeb 02, 2017 10:46 am

NetworkNewsBreaks – xG Technology, Inc. (NASDAQ: XGTI) Shares Surge on Acquisition of Vislink Communication Systems

Shares of xG Technology (NASDAQ: XGTI) are higher 23% in morning trade following news that the wireless solutions provider has completed its acquisition of Vislink Communication Systems, assuming full ownership of the business. The previously announced acquisition was a $16 million binding asset purchase agreement and was paid for with $6.5 million in cash and a $9.5 million promissory note. xG said it intends to use a combination of new debt and internal funding to pay the promissory note off. To view the full press release, visit: http://nnw.fm/sVyO3 About xG Technology, Inc. xG Technology is a provider of wireless video…

Continue Reading

WednesdayFeb 01, 2017 1:34 pm

NetworkNewsBreaks – Westell Technologies, Inc. (NASDAQ: WSTL) Targets Industry Poised for $486M; “Future-proof” PS71090 Slated for Release Q1 2017

Since its founding in 1980, Westell Technologies (NASDAQ: WSTL) has expanded and acclimated to the evolving, high-performance wireless infrastructure solutions industry, offering today’s most technologically advanced in-building wireless, intelligent site management, cell site optimization and outside plant solutions. In November, the company announced the newest member of its in-building wireless coverage solutions portfolio, PS71090 Signal Booster. The “future-proof” solution was designed to meet the strict requirements of the National Fire Alarm Code NFPA 72 standards, as well as the anticipated First Responder Network Authority (FirstNet) requirements. The PS71090 is expected to be generally available in the first quarter of 2017,…

Continue Reading

WednesdayFeb 01, 2017 1:31 pm

NetworkNewsBreaks – First Choice Healthcare Solutions, Inc. (FCHS) – Transforming Healthcare Delivery for Doctors and Patients

Quality and distinction matter at First Choice Healthcare Solutions (OTCQB: FCHS). Indeed, the company’s model for success is based on the premise that doctors get to be doctors at its Medical Centers of Excellence and, consequently, patients get excellent “personalized” care. A talented team of healthcare experts and executives are at the helm at First Choice, leveraging a shared vision and tested experience to steer the company’s patient-centric culture, daily operations, smart growth strategies, and long-term value creation. With their guidance, the company is developing its Centers into superior clinical destinations that will offer more significant and collaborative doctor-patient interactions,…

Continue Reading